Diversified Consumer Services
Company Overview of The University of Pennsylvania
University of Pennsylvania is an educational institution offering graduate, undergraduate, professional, summer courses, and distance learning programs in fields such as law, medicines, communication, and dental medicine. The schools of the university include School of Arts and Sciences; Annenberg School for Communication; School of Dental Medicine; Graduate School of Education; School of Engineering and Applied Science; Graduate School of Fine Arts; Law School; School of Medicine; School of Nursing; School of Social Work; School of Veterinary Medicine; and Wharton School. University of Pennsylvania was established in 1740 and is based in Philadelphia, Pennsylvania. The university has endowm...
3451 Walnut Street
Philadelphia, PA 19104
Founded in 1740
Key Executives for The University of Pennsylvania
Dean of the School of Design
Associate, Licensing and New Business Start-Up at Center for Technology Transfer
Compensation as of Fiscal Year 2014.
The University of Pennsylvania Key Developments
University of Pennsylvania and the Wharton School Launch Penn Wharton China Center
Mar 10 15
The University of Pennsylvania and the Wharton School of the University of Pennsylvania announced the opening of the Penn Wharton China Center in Beijing, China. The Center is an important expansion of Penn's engagement with China, which began in 1896 when the first Chinese student enrolled at Penn. It will operate through the University's China based affiliate, Penn Wharton Consulting (Beijing) Co, LTD. The Center will serve as a valuable resource and vibrant gathering place enhancing learning and research opportunities to the benefit of Penn's faculty, students, alumni and friends in China. Through its consulting programs, it will also support Chinese executives and others in acquiring the practical skills and perspectives that will help them successfully lead their organizations in a global context. To celebrate the opening, Provost Price will lead a delegation of more than 40 faculty and senior administrators from Penn that includes Vice Provost for Global Initiatives Ezekiel Emanuel, Dean of the Wharton School Geoffrey Garrett and seven other Penn deans. They are convening a two-day series of academic discussions this month featuring a roundtable with Chinese university leaders to discuss issues in higher education, panel discussions with senior Chinese business leaders and Penn scholars, and research talks with Penn faculty and deans.
University of Pennsylvania and University of Georgia Scientists Wins New Contract from the National Institutes of Allergy and Infectious Disease
Dec 18 14
A genome database team led by University of Pennsylvania and University of Georgia scientists has been awarded a new contract from the National Institutes of Allergy and Infectious Disease worth $4.3 million in 2014 to 2015. Assuming annual renewal, this five-year award is expected to total $23.4 million. The team has been responsible for developing genome database resources for microbial pathogens, including the parasites responsible for malaria, sleeping sickness, toxoplasmosis and many other important diseases. The new contract ensures work will continue on the Eukaryotic Pathogen Genomics Database known as EuPathDB to provide the global scientific community with free access to a wealth of genomic data related to microbial pathogens important to human health and bio-security. EuPathDB expedites biomedical research in the lab, field and clinic, enabling the development of innovative diagnostics, therapies and vaccines. The latest contract is the third time that NIH has awarded support to EuPathDB, building on previous contracts issued in 2004 and 2009 as well as prior grant funding from the NIH and the Burroughs Wellcome Fund.
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria
Oct 21 14
Inovio Pharmaceuticals, Inc. announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune. The group will develop DNA-based monoclonal antibodies (mAbs) for infectious disease treatment. DARPA is an agency of the US Department of Defense that creates and supports novel technologies important for national security. Together, the three organizations will develop and assess the DNA mAbs in preclinical studies using technology developed by Penn and licensed by Inovio. The collaboration will focus on three disease areas -- influenza virus, Pseudomonas aeruginosa and Staphylococcus aureus. This collaboration aims to demonstrate that the DNA plasmids containing optimized DNA sequences encoded to generate disease-specific mAbs can activate sufficient quantities of specific antibodies in the body to be protective against a pathogen challenge. Using the capabilities and advantages of synthetic DNA plasmids delivered using electroporation, the team will construct and evaluate multiple DNA mAbs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|